U.S. Sodium Lactate Market for Pharmaceutical Industries, By Dosage Form (Injection, Solution, Concentrate), Population Type (Pediatrics, Adults), Application (Intravenous Fluids, CAPD, Dialysis Solution, PH Regulation, Metal Sequestration, Chiral Intermediate, Anti-Inflammatory Agent), End User (Hospitals, Clinics, Home Healthcare, Others), Distribution Channel (Direct Tenders, Retail Sales, Others) - Industry Trends and Forecast to 2031.
U.S. Sodium Lactate Market for Pharmaceutical Industries Analysis and Size
The U.S. sodium lactate market for pharmaceutical industries is expected to grow significantly in the forecast period of 2024 to 2031. The major factors driving the growth of the market are the increasing trend of using sodium lactate by pharma companies, rising CAPD procedures in the U.S., use of sodium lactate in topical dermatological products, and increasing use of metal sequestration in pharma products.
Data Bridge Market Research analyzes that the U.S. sodium lactate market for pharmaceutical industries which was USD 29.90 million in 2023, is expected to reach USD 66.83 million by 2031, growing at a CAGR of 10.7% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.
U.S. Sodium Lactate Market for Pharmaceutical Industries Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Dosage Form (Injection, Solution, Concentrate), Population Type (Pediatrics, Adults), Application (Intravenous Fluids, CAPD, Dialysis Solution, PH Regulation, Metal Sequestration, Chiral Intermediate, Anti-Inflammatory Agent), End User (Hospitals, Clinics, Home Healthcare, Others), Distribution Channel (Direct Tenders, Retail Sales, Others)
|
|
Country Covered
|
U.S.
|
|
Market Players Covered
|
AdvaCare Pharma (China), Pfizer Inc (U.S.), Viatris Inc (U.S.), Corbion (Netherlands), Dr. Paul Lohmann GMBH & CO.KGAA (Germany), Baxter (U.S.), B.Braun Melsungen AG (Germany)
|
|
Market Opportunities
|
|
Market Definition
Sodium lactate is sodium salt of lactic acid. It is also called monosodium salt and lactic acid sodium salt. In pharmaceutical industry, sodium lactate is given intravenously as a source of bicarbonate for regulating or preventing mild to moderate metabolic acidosis in patients with limited oral ingestion whose oxidative processes are not seriously impaired. Sodium lactate is also used to treat arrhythmia caused by overdosing of class I antiarrhythmic, as well as sympathomimetic which can cause hypertension.
U.S. Sodium Lactate Market for Pharmaceutical Industries Dynamics
Drivers
- Rising Pharmaceutical Manufacturing
The growing pharmaceutical industry worldwide, driven by an increasing global population and prevalence of diseases, generates higher demand for pharmaceutical ingredients like sodium lactate used in various formulations.
- Enhanced Shelf Life and Stability
Sodium lactate's ability to extend the shelf life and enhance stability in pharmaceutical formulations, especially in parenteral solutions, injectables, and oral medications, is a significant driver for its use in the industry.
Opportunity
- Rising Preference for Natural and Safe Ingredients
As there is an increasing consumer preference for natural and safe ingredients in pharmaceutical products, sodium lactate being a natural compound derived from fermentation processes gains favor compared to synthetic alternatives.
- Growing Focus on Intravenous Therapies
Sodium lactate is used in intravenous solutions for fluid and electrolyte replenishment, driving its demand due to the rising emphasis on intravenous therapies in the healthcare sector.
Restraints/Challenges
- Availability of Alternative Ingredients
The availability of alternative pharmaceutical ingredients that can perform similar functions as sodium lactate might pose a challenge to its market growth. Substitutes or newer compounds offering similar or enhanced functionalities could impact its demand.
- Price Volatility of Raw Materials
Fluctuations in the prices of raw materials used in the production of sodium lactate can impact its overall manufacturing cost. Instability in raw material prices can affect the profitability of manufacturers and subsequently influence the market.
This U.S. sodium lactate market for pharmaceutical industries report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the sodium lactate market for pharmaceutical industries contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth
Recent Developments
- In March 2021, Corbion announced that the company has decided to boost the lactic acid production capacity through a series of concurrent expansion projects. This will increase the market for Corbion and will add up the revenue of the company in the forecasted period
- In October 2020, Viatris Inc a combined company of Mylan and Pfizer Inc. received clearance from U.S Federal Trade Commission. This approval paved the way for the establishment of new company having great emphasis on development of innovative medicines and breakthrough in order to change patient’s lives. This approval unlocked the future for company growth
- In September 2020, Viatris Inc, a combined company of Mylan and Pfizer Inc. received EU approval. Moreover, the company also achieved approval from Australian competition, consumer commission, and New Zealand commission that have strengthened its proposal of company establishment. This approval allowed the company launches new company that is positioned to meet patients need
Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays
Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions. Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.
Expected Impact of Economic Slowdown on the Pricing and Availability of Products
When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.
U.S. Sodium Lactate Market for Pharmaceutical Industries Scope
The sodium lactate market for pharmaceutical industries is segmented into five notable segments, based on dosage form, population type, application, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Dosage Form
- Injection
- Solution
- Concentrate
Population Type
- Pediatrics
- Adults
Application
- Intravenous Fluids
- CAPD
- Dialysis Solution
- pH Regulation
- Metal Sequestration
- Chiral Intermediate
- Anti-Inflammatory Agent
End User
- Hospitals
- Clinics
- Home Healthcare
- Others
Distribution Channel
- Direct Tenders
- Retail Sales
- Others
Competitive Landscape and U.S. Sodium Lactate Market for Pharmaceutical Industries Share Analysis
The sodium lactate market for pharmaceutical industries competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to sodium lactate market for pharmaceutical industries.
Some of the major players operating in the sodium lactate market for pharmaceutical industries are:
- AdvaCare Pharma (China)
- Pfizer Inc (U.S.)
- Viatris Inc (U.S.)
- Corbion (Netherlands)
- Dr. Paul Lohmann GMBH & CO.KGAA (Germany)
- Baxter (U.S.)
- B.Braun Melsungen AG (Germany)
SKU-